United States · FDA National Drug Code directory
Neomycin and Polymyxin B Sulfates and Dexamethasone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61314-630_a2bce951-7394-4d72-a7af-7a6c9de35d7e
- Product NDC
- 61314-630
- Form
- SUSPENSION
- Composition / generic term
- neomycin sulfate, polymyxin b sulfate and dexamethasone
- Labeler
- Sandoz Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19960221
- Source listing expiry
- 20271231
Source-listed ingredients
- NEOMYCIN SULFATE — 3.5 mg/mL
- POLYMYXIN B SULFATE — 10000 [USP'U]/mL
- DEXAMETHASONE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 mL in 1 BOTTLE, PLASTIC (61314-630-06) · 61314-630-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →